1.Centers for Disease Control and Prevention (2017) .
2.Korbel, L and Spencer, J (2015) Diabetes mellitus and infection: an evaluation of hospital utilization and management costs in the United States. Journal of Diabetes and its Complications 29, 192–195.
3.Dryden, M et al. (2015) Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections. Clinical Microbiology and Infection 21(suppl 2), S27–S32.
4.Peleg, AY et al. (2007) Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes/Metabolism Research and Reviews 23, 3–13.
5.Torres, A et al. (2015) Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease. Thorax 70, 984–989.
6.Casqueiro, J and Alves, C. (2012) Infections in patients with diabetes mellitus: a review of pathogenesis. Indian Journal of Endocrinology and Metabolism 6(suppl 1), S27–S36.
7.Avishai, E, Yeghiazaryan, K and Golubnitschaja, O (2017) Impaired wound healing: facts and hypotheses for multi-professional considerations in predictive, preventive and personalised medicine. The EPMA Journal 8, 23–33.
8.Muller, L et al. (2005) Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clinical Infectious Diseases 41, 281–288.
9.Collaboration TERF (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. New England Journal of Medicine 364, 829–841.
10.Yende, S et al. (2010) The influence of pre-existing diabetes mellitus on the host immune response and outcome of pneumonia: analysis of two multicentre cohort studies. Thorax 65, 870–877.
11.Martins, M et al. (2016) Diabetes hinders community-acquired pneumonia outcomes in hospitalized patients. BMJ Open Diabetes Research & Care 4, e000181.
12.Polsky, D, Bonafede, M and Suaya, J (2012) Comorbidities as a driver of the excess costs of community-acquired pneumonia in U.S. commercially-insured working age adults. BMC Health Services Research 12, 379.
13.Tong, S et al. (2018) Trends in healthcare utilization and costs associated with pneumonia in the United States during 2008–2014. BMC Health Services Research 18, 715.
14.Falagas, M, Mourtzoukou, E and Vardakas, K (2007) Sex differences in the incidence and severity of respiratory tract infections. Respiratory Medicine 101, 1845–1863.
15.Raine, R et al. (2002) Influence of patient gender on admission to intensive care. Journal of Epidemiology and Community Health 56, 418–423.
16.Fine, M et al. (1997) A prediction rule to identify low-risk patients with community-acquired pneumonia. New England Journal of Medicine 336, 243–250.
17.Kaplan, V et al. (2002) Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. American Journal of Respiratory and Critical Care Medicine 165, 766–772.
18.Manicardi, V et al. (2016) Gender-disparities in adults with type 1 diabetes: more than a quality of care issue. A cross-sectional observational study from the amd annals initiative. PLoS ONE 11, e0162960.
19.Regitz-Zagrosek, V (2012) Sex and gender differences in health: Science & Society Series on Sex and Science. EMBO Reports 13, 596–603.
20.Kornum, J et al. (2008) Diabetes, glycemic control, and risk of hospitalization with pneumonia: a population-based case-control study. Diabetes Care 31, 1541–1545.
21.Huijts, S et al. (2017) Post-hoc analysis of a randomized controlled trial: diabetes mellitus modifies the efficacy of the 13-valent pneumococcal conjugate vaccine in elderly. Vaccine 35, 4444–4449.
22.Slinin, Y, Foley, R and Collins, A (2006) Clinical epidemiology of pneumonia in hemodialysis patients: the USRDS waves 1, 3, and 4 study. Kidney International 70, 1135–1141.
23.Fine, M et al. (1996) Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. The Journal of the American Medical Association 275, 134–141.
24.Zhang, Y et al. (2016) Comparison of dual influenza and pneumococcal polysaccharide vaccination with influenza vaccination alone for preventing pneumonia and reducing mortality among the elderly: a meta-analysis. Human Vaccines & Immunotherapeutics 12, 3056–3064.
25.Vamos, E et al. (2016) Effectiveness of the influenza vaccine in preventing admission to hospital and death in people with type 2 diabetes. CMAJ: Canadian Medical Association Journal 188, E342–E351.
26.Cafiero-Fonseca, E et al. (2017) The full benefits of adult pneumococcal vaccination: a systematic review. PLoS ONE 12, e0186903.
27.Li, C, Gubbins, P and Chen, G (2015) Prior pneumococcal and influenza vaccinations and in-hospital outcomes for community-acquired pneumonia in elderly veterans. Journal of Hospital Medicine 10, 287–293.
28.Fisman, D et al. (2006) Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia. Clinical Infectious Diseases 42, 1093–1101.
29.Williams, W et al. (2016) Surveillance of vaccination coverage among adult populations – United States, 2014. Morbidity and Mortality Weekly Report Surveillance Summaries (Washington, DC: 2002) 65, 1–36.
30.Lu, PJ et al. (2017) Awareness among adults of vaccine-preventable diseases and recommended vaccinations, United States, 2015. Vaccine 35, 3104–3115.
31.Jones, L et al. (2010) Understanding the reasons for the underuse of pneumococcal vaccination by community-dwelling older African Americans. Journal of the American Geriatrics Society 58, 2323–2328.
32.Eisele, P (2017) .